{"database": "lobbying", "table": "lobbying_activities", "rows": [[821753, "1cb157ad-b6f3-4223-b8e0-c6b3a4f963fe", "Q3", "DUTKO WORLDWIDE, LLC", 12868, "GLAXOSMITHKLINE", 2009, "third_quarter", "CPT", "Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & as it relates to comparative effectiveness research funding.  America's Affordable Health Choices\nAct of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned).  Pharmaceutical import safety legislation.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2009-10-01T11:09:56-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["821753"], "units": {}, "query_ms": 104.72522501368076, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}